Autism Spectrum Disorder Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Children and adolescents between 5 and 12 years old at the time of screening
• People who have been diagnosed with ADHD or Autism Spectrum Disorder (ASD) by a psychiatrist, using standard diagnostic guidelines (DSM-5); for ASD, the diagnosis may also be supported by specific standardised assessment tools
• People whose IQ score is 65 or above, as measured by a standard intelligence test
• People who are able to use a tablet-based app called 'NDTx-02', either on their own or with help from a parent or guardian
• People who are able to follow the recommended app schedule, which involves 30 sessions over 6 weeks, used 5 times per week
• People whose parent or guardian agrees not to start or change any treatments, therapies, or medications during the study period — continuing existing treatments is allowed
• People whose parent or legal guardian voluntarily agrees to take part and signs a written consent form
• People willing to follow all clinical trial procedures

Who may not be able to join:

• People who have significant behavioural problems, difficulty regulating emotions, psychotic symptoms, or risk of self-harm or harm to others that could interfere with the treatment process
• People with a severe ongoing or long-term medical or mental health condition
• People who have experienced serious trauma or had surgery within the 4 weeks before screening
• People with other significant disabilities, such as serious neurological conditions (for example, brain lesions or certain mental disorders)
• People who are currently in another clinical trial, or who have taken part in one within the 30 days before screening
• People whose medication dose or type — particularly medications that could affect thinking or concentration — has changed within the 4 weeks before the baseline visit
• People who have started or changed a therapy, education, or rehabilitation program that could significantly affect thinking or concentration within the 4 weeks before the baseline visit
• People who have taken part in a clinical trial of, or previously used, software designed to improve thinking skills or daily living within the 12 weeks before the baseline visit
• People whom the trial investigator considers unsuitable for participation for ethical reasons or because their participation could affect the reliability of the trial results

Important: Always verify eligibility with the trial site directly before applying.